Using SGLT2-inhibitors to treat cardiac patients with diabetes

At our 2018 symposium, "Management of Type 2 Diabetes in Patients with CVD: Focus on Heart Failure," nephrologist and scientist Dr. David Cherney explores the use of SGLT2-inhibitors in cardiovascular and renal protection.

Пікірлер: 14

  • @RoshanLovesall
    @RoshanLovesall3 жыл бұрын

    Beautiful explaination. Continue the good work

  • @bishopecart
    @bishopecart3 жыл бұрын

    Awesome study as it relates to HFrEF

  • @RM-hq7wn
    @RM-hq7wn6 ай бұрын

    Very nice 👍

  • @mattiaslarsson4085
    @mattiaslarsson40852 жыл бұрын

    Great!

  • @ahmedahm1
    @ahmedahm12 жыл бұрын

    2:42 Good explanation ! So can patients with prediabetes and microalbuminuria take SGLT2i ?

  • @adrienmonk2469
    @adrienmonk24692 жыл бұрын

    Im sorru sir , but the is not a cotransporter Na /K /2Cl in the distal tubel lumen . you heve to corrcte that .

  • @lexus0077
    @lexus0077 Жыл бұрын

    SGLT 2 ??? ,What is this ?

  • @oswaldfernandes8266
    @oswaldfernandes82663 жыл бұрын

    Statistical analysis of covid deaths in diabetics on sglt2 inhibitors will provide the answer

  • @oswaldfernandes8266
    @oswaldfernandes82663 жыл бұрын

    The drug is a killer in diabetic covid patients. This fact outweighs the benefits of the drug in view of the pandemic as I have lost my brother Simon because of sglt2 inhibitors

  • @amosjuliantampubolon2413

    @amosjuliantampubolon2413

    2 жыл бұрын

    Covid patient can consume it?

  • @prettyyoungthingpyt5015

    @prettyyoungthingpyt5015

    Жыл бұрын

    This drug dehydrated like hell. You have to be extremely careful with this damn drug. I think I'll stick to insulin.

Келесі